PFE Headlines | Pfizer, Inc. Common Stock Stock - Yahoo! Finance

Sat, May 26, 2012, 7:04AM EDT - U.S. Markets closed

Dow

0.60% Nasdaq

0.07%

More On PFE

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Pfizer Inc. (PFE)

-NYSE

22.13 0.01(0.05%) May 25, 4:00PM EDT|After Hours: 22.10 0.03 (0.14%) May 25, 6:26PM EDT

Add to Portfolio

Headlines

Get Headlines for:

	Filter Headlines

Friday, May 25, 2012

Half A Trillion In Pentagon Budget Cuts Turns Defense Stocks Into Dividend Darlingsat Forbes (Fri, May 25)
Final Glance: Pharmaceuticals companiesAP (Fri, May 25)
[video] Be Like Rockefeller, Get Rich On Dividendsat Forbes (Fri, May 25)
Biogen Tysabri Canadian Label UpdateZacks (Fri, May 25)
The Meaningless Drug Approval That Could Cost the Industry Billionsat Motley Fool (Fri, May 25)
Reports: Sanofi, Merck Bid At Least $25 Per Share For Amylinat Barrons.com (Fri, May 25)
United Technologies $9.8B Mega-Bond Deal Surgesat Barrons.com (Fri, May 25)
2 Dow 30 Stocks Enjoying the Bounceat Wall St. Cheat Sheet (Fri, May 25)
Midday Glance: Pharmaceuticals companiesAP (Fri, May 25)
Shareholder Activism More Focused, Targetedat Fox Business (Fri, May 25)
Pfizer Kidney Cancer Drug Nears Approval In Europeat Investor's Business Daily (Fri, May 25)
Largest option buying in equities so faroptionMONSTER (Fri, May 25)
Early Glance: Pharmaceuticals companiesAP (Fri, May 25)
Pfizer says EU recommends approval of InlytaAP (Fri, May 25)
Pfizer Drug for Rare Disease Shouldn't Be Approved, US Review Says [UPDATE]at Minyanville (Fri, May 25)
InPlay: Pfizer's Axitinib receives positive opinion from the CHMP for the second-line treatment of advanced kidney cancer in the EUBriefing.com (Fri, May 25)
Pfizer’s Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EUBusiness Wire (Fri, May 25)
Perception, Opportunity in Volatility - Research & Analysis on Pfizer Inc. and Alcoa Inc.Marketwire (Fri, May 25)
Pfizer: A $22 Stock Worth $25at Seeking Alpha (Fri, May 25)
Takeda chases emerging market sales with Brazil buyat Reuters (Fri, May 25)

Older Headlines

Add PFE News to My Yahoo!

Copyright © 2010 Yahoo! All rights reserved. Privacy Policy - About Our Ads - Terms of Service - Copyright Policy - Report Problems

Quotes for NYSE, Nasdaq and NYSEAmex are Real-time and sourced from Nasdaq Last Sale when available. If not available from NLS, quotes will appear delayed from primary listing source.
See also delay times for other exchanges. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page.Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.